Pixium Financial Statements From 2010 to 2026
| PXMVFDelisted Stock | USD 1.50 1.47 4,900% |
Check Pixium Vision financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pixium Vision's main balance sheet or income statement drivers, such as , as well as many indicators such as . Pixium financial statements analysis is a perfect complement when working with Pixium Vision Valuation or Volatility modules.
Pixium |
Pixium Vision SA Company Return On Equity Analysis
Pixium Vision's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pixium Vision Return On Equity | -5.77 |
Most of Pixium Vision's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pixium Vision SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Pixium Vision SA has a Return On Equity of -5.7657. This is 75.95% lower than that of the Healthcare sector and 3.58% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is notably higher than that of the company.
Pixium Vision SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pixium Vision's current stock value. Our valuation model uses many indicators to compare Pixium Vision value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pixium Vision competition to find correlations between indicators driving Pixium Vision's intrinsic value. More Info.Pixium Vision SA is rated below average in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pixium Vision's earnings, one of the primary drivers of an investment's value.About Pixium Vision Financial Statements
Pixium Vision stakeholders use historical fundamental indicators, such as Pixium Vision's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pixium Vision investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pixium Vision's assets and liabilities are reflected in the revenues and expenses on Pixium Vision's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pixium Vision SA. Please read more on our technical analysis and fundamental analysis pages.
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. Pixium Vision SA was founded in 2011 and is based in Paris, France. Eurofins Scientific operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 28 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Pixium Pink Sheet
If you are still planning to invest in Pixium Vision SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pixium Vision's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |